0000
Dongwha Pharm Co., Ltd. (000020)
Market Closed
25 Jul, 06:30
KRX SM KRX SM Primary ₩
6,780. 00
-20
-0.29%
₩
194.03B Market Cap
- P/E Ratio
720% Div Yield
34,918 Volume
- Eps
₩ 6,800
Previous Close Day Range
6,750 6,820
Year Range
5,600 8,560
Want to track 000020 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
000020 closed yesterday lower at ₩6,780, a decrease of 0.29% from Thursday's close, completing a monthly increase of or ₩6,780. Over the past 12 months, 000020 stock gained .
000020 is not paying dividends to its shareholders.
The last earnings report, released on Nov 13, 2024, missed the consensus estimates by -11.1%. On average, the company has surpassed earnings expectations by 74.6%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).
000020 Chart
Loading, please wait...
Dongwha Pharm Co., Ltd. Dividends
| 0000 000020 6 months ago | Other | ₩180 Per Share |
| 0000 000020 27 Dec 2023 | Other | ₩180 Per Share |
| 0000 000020 28 Dec 2022 | Other | ₩180 Per Share |
| 0000 000020 29 Dec 2021 | Other | ₩180 Per Share |
| 0000 000020 29 Dec 2020 | Other | ₩180 Per Share |
Dongwha Pharm Co., Ltd. Earnings
| 13 Nov 2024 Date | | - Cons. EPS | - EPS |
| 13 Aug 2024 Date | | - Cons. EPS | 127.09 EPS |
| 20 May 2024 Date | | - Cons. EPS | 107.8 EPS |
| 19 Mar 2024 Date | | - Cons. EPS | 53.02 EPS |
| 20 Nov 2023 Date | | - Cons. EPS | 213.96 EPS |
| 0000 000020 6 months ago | Other | ₩180 Per Share |
| 0000 000020 27 Dec 2023 | Other | ₩180 Per Share |
| 0000 000020 28 Dec 2022 | Other | ₩180 Per Share |
| 0000 000020 29 Dec 2021 | Other | ₩180 Per Share |
| 0000 000020 29 Dec 2020 | Other | ₩180 Per Share |
| 13 Nov 2024 Date | | - Cons. EPS | - EPS |
| 13 Aug 2024 Date | | - Cons. EPS | 127.09 EPS |
| 20 May 2024 Date | | - Cons. EPS | 107.8 EPS |
| 19 Mar 2024 Date | | - Cons. EPS | 53.02 EPS |
| 20 Nov 2023 Date | | - Cons. EPS | 213.96 EPS |
Dongwha Pharm Co., Ltd. (000020) FAQ
What is the stock price today?
The current price is ₩6,780.00.
On which exchange is it traded?
Dongwha Pharm Co., Ltd. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 000020.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 720%.
What is its market cap?
As of today, the market cap is 194.03B.
Has Dongwha Pharm Co., Ltd. ever had a stock split?
No, there has never been a stock split.
Dongwha Pharm Co., Ltd. Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Doh Joon Yoon CEO | KRX SM Exchange | KR7000020008 ISIN |
| KR Country | - Employees | - Last Dividend | 2 Jul 2009 Last Split | - IPO Date |
Overview
Dongwha Pharm.Co.,Ltd is a pioneer in the pharmaceutical industry, based in Seoul, South Korea, with a rich history dating back to 1897. The company specializes in the manufacturing and selling of a diverse range of pharmaceutical products, focusing primarily on the South Korean market. Dongwha Pharm.Co.,Ltd has established itself as a reputable name in the healthcare sector by offering a variety of ethical and over-the-counter (OTC) medications, as well as health-related foods, drinks, cosmetics, and quasi drugs. In addition to serving the domestic market, Dongwha Pharm.Co.,Ltd has expanded its reach by exporting its products to various countries, showcasing its commitment to improving health standards globally.
Products and Services
Dongwha Pharm.Co.,Ltd offers an extensive portfolio of products and services catered to a wide range of health needs:
- Ethical Products: These products target specific health conditions and require a prescription. They cover several therapeutic areas, including alimentary system, antibiotics, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system.
- OTC Products: Available without a prescription, these include remedies for the alimentary system, colds, NSAID/respiratory issues, dermatological concerns, oral health, liver protection, nutrients, tonics, topical analgesics, antihistamines, and sore throat treatments, among others.
- Quasi Drugs: These items include products that have medicinal properties but are not classified strictly as pharmaceuticals. They can serve various purposes, from personal care to health maintenance.
- Health Subsidiary Foods: This category includes dietary supplements and other foods designed to support overall health and well-being, addressing specific dietary needs and nutritional deficiencies.
- Foods and Drinks: Dongwha offers health-focused foods and beverages formulated to complement a healthy lifestyle and provide nutritional benefits beyond what is found in the typical diet.
- Cosmetics: The company also produces cosmetics with an emphasis on skin health, incorporating ingredients that aim to improve the skin's condition while providing aesthetic benefits.
Contact Information
Address: FastFive Tower, Seoul, South Korea, 04522
Phone: 82 2 2021 9300
Website: https://www.dong-wha.co.kr
2025 © Marketlog. All Rights Reserved.
